Genetics & cultivation
RDC 1.013/2026 created regulated domestic cultivation, for medical, pharmaceutical, research and export purposes. This is where agribusiness enters the chain, and legal structure decides who may plant.
- Rule
- Hemp cultivation with up to 0.3% THC by legal entities only, with an ANVISA Special Authorization, a prior health inspection and seed-to-batch traceability. Seed imports follow MAPA Ordinance 1.342/2025.
- Risk
- The authorization belongs to the company, not the farmer. Without the right legal entity and an origin record from the seed, the project stops before planting.
- Opportunity
- Those who get structured first are likely to become suppliers of traceable biomass to the pharmaceutical industry, in Brazil or abroad: RDC 1.023/2026 allows cultivation for export, backed by a buyer’s contract or letter of intent. Growing for fiber, grain or construction still depends on rules from the Agriculture Ministry (MAPA).
Uses of this stage worldwide
- Seed stock
- Biomass
- Phytoremediation
- Carbon credits